Mesenchymal Stem Cells Alleviate Crohn's Disease by Regulating CBS‐Mediated Ferroptosis
Immunity, Inflammation and Disease · 2026
DOI: 10.1002/iid3.70506 ↗Kurz gefasst
Fachartikel in der Zeitschrift Immunity, Inflammation and Disease, 2026. Verfasst von Zhixi Huang und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China. Hauptthemen laut MEDLINE: Crohn Disease, Ferroptosis, Mesenchymal Stem Cells, Mesenchymal Stem Cell Transplantation. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The National Natural Science Foundation of China, The Joint Project on Regional High-Incidence Diseases Research of the Guangxi Natural Science Foundation, The Development and Application of Medical and Health Appropriate Technology Project in Guangxi Zhuang Autonomous Region.
Abstract (Originalsprache)
Background
Mesenchymal stem cells (MSCs) possess immunoregulatory properties and have been shown to alleviate symptoms of Crohn's disease (CD). While ferroptosis has been implicated in the onset of CD, the precise connection between MSCs, CD, and ferroptosis remains unclear. This study sought to explore whether MSCs could alleviate CD by inhibiting ferroptosis. Materials and Methods We screened the hub genes involved in both ferroptosis and CD and validated them in clinical colon biopsies by immunohistochemistry (IHC). MSCs were administered intraperitoneally to mice with colitis induced by trinitrobenzene sulfonic acid (TNBS) enema to evaluate the therapeutic effect. Additionally, a rescue experiment was conducted by co‐treating colitis mice with a cystathionine‐β‐synthase (CBS) inhibitor (aminooxyacetic acid, AOAA) and MSCs to further explore the mechanism of the MSCs‐CBS‐ferroptosis axis. The expression levels of CBS and ferroptosis‐related markers in colonic tissues were assessed by real‐time quantitative polymerase chain reaction (RT‐qPCR), western blot, and IHC.
Results
Bioinformatics and machine learning identified CBS as a hub gene in both CD and ferroptosis. IHC revealed that CBS expression was downregulated in colon tissues from CD patients. MSCs treatment significantly reduced pathological symptoms and intestinal inflammation in colitis mice. MSCs increased CBS expression, which had been diminished in colitis mice. Additionally, MSCs increased glutathione (GSH) and glutathione peroxidase 4 (GPX4) expression, thereby inhibiting ferroptosis activation. In a rescue experiment, co‐treatment with AOAA and MSCs exacerbated intestinal inflammation and reversed the elevation of CBS and ferroptosis‐related markers.
Discussion
This study demonstrates that MSCs alleviate the symptoms of CD by regulating CBS‐mediated ferroptosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.
- Department of Gastroenterology, Guangxi Hospital Division of The First Affiliated Hospital of Sun Yat-sen University, Nanning, China.
- Department of Emergency, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.
- Department of Clinical Experimental Medicine, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.
ORCID-Profile: Xiaofang Xu, Bing Han, Ziqian Huang, Lichun Han, Xiaoping Lv
Förderung
- The National Natural Science Foundation of China
- The Joint Project on Regional High-Incidence Diseases Research of the Guangxi Natural Science Foundation
- The Development and Application of Medical and Health Appropriate Technology Project in Guangxi Zhuang Autonomous Region
- The Self-financing Project of the Health Commission of Guangxi Zhuang Autonomous Region
- The Innovation Project of Guangxi Graduate Education
- The Youth Science Foundation of Guangxi Medical University
- The Guangxi Zhuang Autonomous Region Health Commission of Scientific Research Project
Zitieren
APA
Huang, Z., Xu, X., Huang, Z., Han, B., Jiang, D., Lv, X., Huang, Z., Lin, G., Huang, F., Li, Y., Han, L., Chen, D., Lin, J., & Lv, X. (2026). Mesenchymal Stem Cells Alleviate Crohn's Disease by Regulating CBS‐Mediated Ferroptosis. Immunity, Inflammation and Disease. https://doi.org/10.1002/iid3.70506
Vancouver
Huang Z, Xu X, Huang Z, Han B, Jiang D, Lv X, et al. Mesenchymal Stem Cells Alleviate Crohn's Disease by Regulating CBS‐Mediated Ferroptosis. Immunity, Inflammation and Disease. 2026. doi:10.1002/iid3.70506
BibTeX
@article{Huang2026,
author = {Huang, Zhixi and Xu, Xiaofang and Huang, Zhou and Han, Bing and Jiang, Dan and Lv, Xiaodan and Huang, Ziqian and Lin, Guangfu and Huang, Fengxiang and Li, Yu and Han, Lichun and Chen, Deyi and Lin, Jianing and Lv, Xiaoping},
title = {Mesenchymal Stem Cells Alleviate Crohn's Disease by Regulating CBS‐Mediated Ferroptosis},
journal = {Immunity, Inflammation and Disease},
year = {2026},
doi = {10.1002/iid3.70506}
}
EUVIMED